* Surgery Partners Inc is expected to show a rise in quarterly revenue when it reports results on May 7 for the period ending March 31 2024
* The Brentwood Tennessee-based company is expected to report a 4.8% increase in revenue to $698.031 million from $666.2 million a year ago, according to the mean estimate from 9 analysts, based on LSEG data.
* LSEG's mean analyst estimate for Surgery Partners Inc is for earnings of 7 cents per share.
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the last three months.
* Wall Street's median 12-month price target for Surgery Partners Inc is $43.00, above its last closing price of $25.00.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 0.38 0.38 0.44 Beat 16.2
Sep. 30 2023 0.18 0.16 0.19 Beat 16.5
Jun. 30 2023 0.09 0.08 0.28 Beat 245.3
Jan. 1 0001 0.00 0.00 0.08 Beat 1,951.
3
Dec. 0.19 0.19 0.27 Beat 45.9
31 2022
Sep. 30 2022 0.03 0.05 -0.02 Missed -143.8
Jan. 1 0001 -0.01 -0.01 -0.03 Missed -344.4
Jan. 1 0001 -0.06 -0.06 -0.09 Missed -47.5
This summary was machine generated May 3 at 14:30 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments